MRK's Winrevair Phase III Study in Newly Diagnosed PAH Meets Goal

• click to rate

  Posted by Two Blokes Jun 24 - Filed in Stock - 3 views
  
  Merck's Winrevair meets goal in a phase III study in newly diagnosed PAH patients, showing strong efficacy.